TIDMNIM 
 
RNS Number : 7045W 
Norwood Immunology Ld 
03 August 2009 
 
3 August 2009 
 
 
 
 
Norwood Immunology Limited 
Results of EGM 
De-Listing, Equal Access Buy-Back and Streamlining of Operations 
 
 
Norwood Immunology Limited ('Norwood Immunology' or 'the Group') (AIM:NIM), the 
Group with technologies in the fields of the rejuvenation of the immune system 
and stem cell therapies, today announces the results of its EGM, held on 31 July 
2009. 
All the resolutions proposed at the EGM were unanimously approved by those 
shareholders casting a vote and, accordingly have been adopted. 
The company received acceptances for its Equal Access Buy-Back Scheme for 
42,115,879, an amount within the Buy-Back Limit (as defined in the Notice of 
EGM) and accordingly the Company will be proceeding to purchase and then cancel 
these shares. 
The Board will also be implementing the streamlining proposals set out in the 
EGM including the   cancellation of the Company's admission to AIM to take 
effect at 7.00 a.m. on 10 August 2009 (following the passing of the resolution 
to de-list with 100% of votes cast in favour). 
 
 
Enquiries: 
 
 
+---------------------------------------+---------------------------------------+ 
| Norwood Immunology                    | +44 (0) 7860 295153                   | 
+---------------------------------------+---------------------------------------+ 
| Richard Williams, Chief Executive     |                                       | 
| Officer                               |                                       | 
+---------------------------------------+---------------------------------------+ 
|                                       |                                       | 
+---------------------------------------+---------------------------------------+ 
| KBC Peel Hunt Ltd (NOMAD & Broker)    | +44 (0) 20 7418 8900                  | 
+---------------------------------------+---------------------------------------+ 
| Capel Irwin                           |                                       | 
+---------------------------------------+---------------------------------------+ 
| David Anderson                        |                                       | 
+---------------------------------------+---------------------------------------+ 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 REGUAAVRKNRBOAR
Norwood Immunology (LSE:NIM)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Norwood Immunology Charts.
Norwood Immunology (LSE:NIM)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Norwood Immunology Charts.